Vivos Therapeutics (VVOS) Shares Outstanding (2019 - 2026)

Vivos Therapeutics (VVOS) has 7 years of Shares Outstanding (Entity) data on file, last reported at $9.3 million in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 57.68% year-over-year to $9.3 million in Q4 2025; TTM through Dec 2025 was $9.3 million, a 57.68% increase from a year earlier, with the FY2025 full-year figure at $9.3 million, up 57.68% from the prior year.
• Shares Outstanding (Entity) for Q4 2025 stood at $9.3 million, down from $11.0 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for VVOS reached as high as $920.5 million in Q4 2022 and fell as low as $728485.0 in Q1 2021.
• Historically, Shares Outstanding (Entity) has averaged $134.1 million across 5 years, with a median of $3.1 million in 2024.
• Across the five-year window, Shares Outstanding (Entity) jumped 99899.97% in 2022 and tumbled 99.87% in 2023, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $920485.0 in 2021, then soared by 99899.97% to $920.5 million in 2022, then tumbled by 99.87% to $1.2 million in 2023, then surged by 382.99% to $5.9 million in 2024, then soared by 57.68% to $9.3 million in 2025.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $9.3 million in Q4 2025, $11.0 million in Q3 2025, and $7.3 million in Q2 2025.